Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2020 $ 2,000 $ 186,559,000 $ (172,246,000) $ (5,610,000) $ 8,705,000
Beginning balance, shares at Mar. 31, 2020 1.55 1,777,483        
Stock based compensation related to common stock restricted stock grants 18,000 18,000
Stock based compensation related to common stock restricted stock grants, shares   3,086        
Conversion of Series C convertible preferred stock into common stock
Conversion of Series C convertible preferred stock into common stock, shares   17,222        
Issuance of common stock due to warrant exercises 1,490,000 1,490,000
Issuance of common stock due to warrant exercises, shares   169,167        
Stock based compensation, net of forfeitures 45,000   45,000
Foreign currency translation adjustment 167,000 167,000
Net income 240,000 240,000
Ending balance, value at Jun. 30, 2020 $ 2,000 188,112,000 (172,006,000) (5,443,000) 10,665,000
Ending balance, shares at Jun. 30, 2020 1,966,958        
Beginning balance, value at Mar. 31, 2020 $ 2,000 186,559,000 (172,246,000) (5,610,000) 8,705,000
Beginning balance, shares at Mar. 31, 2020 1.55 1,777,483        
Net income           360,000
Ending balance, value at Sep. 30, 2020 $ 2,000 188,701,000 (171,886,000) (5,255,000) 11,562,000
Ending balance, shares at Sep. 30, 2020 2,041,409        
Beginning balance, value at Jun. 30, 2020 $ 2,000 188,112,000 (172,006,000) (5,443,000) 10,665,000
Beginning balance, shares at Jun. 30, 2020 1,966,958        
Issuance of common stock due to options exercises 429,000 429,000
Issuance of common stock due to options exercises, Shares   74,451        
Stock based compensation, net of forfeitures 160,000 160,000
Foreign currency translation adjustment 188,000 188,000
Net income 120,000 120,000
Ending balance, value at Sep. 30, 2020 $ 2,000 188,701,000 (171,886,000) (5,255,000) 11,562,000
Ending balance, shares at Sep. 30, 2020 2,041,409        
Beginning balance, value at Mar. 31, 2021 $ 2,000 189,217,000 (179,277,000) (4,579,000) 5,363,000
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Conversion of Series C convertible preferred stock into common stock, shares (1.55)          
Transaction costs related to ATM agreement offering (10,000) (10,000)
Stock based compensation, net of forfeitures 56,000 56,000
Stock based compensation related to issuance of restricted common stock 3,000 3,000
Foreign currency translation adjustment 307,000 307,000
Net income (1,098,000) (1,098,000)
Ending balance, value at Jun. 30, 2021 $ 2,000 189,266,000 (180,375,000) (4,272,000) 4,621,000
Ending balance, shares at Jun. 30, 2021 2,092,909        
Beginning balance, value at Mar. 31, 2021 $ 2,000 189,217,000 (179,277,000) (4,579,000) 5,363,000
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Net income           (1,198,000)
Ending balance, value at Sep. 30, 2021 $ 3,000 196,438,000 (180,475,000) (4,506,000) 11,460,000
Ending balance, shares at Sep. 30, 2021 3,004,741        
Beginning balance, value at Jun. 30, 2021 $ 2,000 189,266,000 (180,375,000) (4,272,000) 4,621,000
Beginning balance, shares at Jun. 30, 2021 2,092,909        
Issuance of common stock in connection with ATM, net of transaction costs $ 1,000 6,901,000 6,902,000
Issuance of common stock in connection with ATM, net of transaction costs, Shares   855,500        
Issuance of common stock due to options exercises 193,000 193,000
Issuance of common stock due to options exercises, Shares   44,042        
Issuance of common stock due to warrant exercises 23,000 23,000
Issuance of common stock due to warrant exercises, shares   12,290        
Stock based compensation related to issuance of restricted common stock 3,000 3,000
Foreign currency translation adjustment (234,000) (234,000)
Net income (100,000) (100,000)
Employee stock-based compensation expense 52,000 52,000
Ending balance, value at Sep. 30, 2021 $ 3,000 $ 196,438,000 $ (180,475,000) $ (4,506,000) $ 11,460,000
Ending balance, shares at Sep. 30, 2021 3,004,741